Day-Long Glycemic Control is Improved and Circulating Leptin Concentrations are Increased in Female Patients with Type-1 Diabetes Treated with Lispro versus Nph/Regular Insulin
Restricted accessResearch articleFirst published online January, 2004
Day-Long Glycemic Control is Improved and Circulating Leptin Concentrations are Increased in Female Patients with Type-1 Diabetes Treated with Lispro versus Nph/Regular Insulin